Back to Menu
Endometrial Cancer Treatment Modalities
1.Comprehensive surgical staging The standard procedure, including hysterectomy with bilateral adnexectomy and lymph node dissection, providing the basis for staging and treatment planning.
2.Minimally invasive surgery Laparoscopic or robot-assisted surgery, associated with less trauma and faster recovery, with efficacy comparable to open surgery.
3.Sentinel lymph node biopsy Suitable for early-stage patients, enabling precise assessment of nodal status while reducing postoperative complications.
4.Radiotherapy Used as adjuvant therapy after surgery or for patients who are not surgical candidates, and can effectively reduce the risk of local recurrence.
5.Chemotherapy Typically platinum-based, used as adjuvant therapy for advanced, recurrent, or high-risk disease.
6.Hormonal therapy Primarily used for estrogen receptor–positive advanced or recurrent disease and requires long-term maintenance therapy.
7.Targeted therapy Including anti-angiogenic agents, providing new treatment options for selected patients with advanced disease.
8.Immunotherapy PD-1/PD-L1 inhibitors have demonstrated favorable efficacy in patients with MSI-H/dMMR tumors.
Conclusion
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes the importance of early screening and standardized treatment for endometrial cancer. Stage-adapted individualized strategies integrating surgery, chemoradiotherapy, and targeted approaches can substantially improve outcomes and quality of life.
Endometrial Cancer Treatment Modalities
1.Comprehensive surgical staging The standard procedure, including hysterectomy with bilateral adnexectomy and lymph node dissection, providing the basis for staging and treatment planning.
2.Minimally invasive surgery Laparoscopic or robot-assisted surgery, associated with less trauma and faster recovery, with efficacy comparable to open surgery.
3.Sentinel lymph node biopsy Suitable for early-stage patients, enabling precise assessment of nodal status while reducing postoperative complications.
4.Radiotherapy Used as adjuvant therapy after surgery or for patients who are not surgical candidates, and can effectively reduce the risk of local recurrence.
5.Chemotherapy Typically platinum-based, used as adjuvant therapy for advanced, recurrent, or high-risk disease.
6.Hormonal therapy Primarily used for estrogen receptor–positive advanced or recurrent disease and requires long-term maintenance therapy.
7.Targeted therapy Including anti-angiogenic agents, providing new treatment options for selected patients with advanced disease.
8.Immunotherapy PD-1/PD-L1 inhibitors have demonstrated favorable efficacy in patients with MSI-H/dMMR tumors.
Conclusion
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes the importance of early screening and standardized treatment for endometrial cancer. Stage-adapted individualized strategies integrating surgery, chemoradiotherapy, and targeted approaches can substantially improve outcomes and quality of life.